Bank of New York Mellon’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.48B | Buy |
|
|||||
|
2025
Q2 | $1.38B | Sell |
|
|||||
|
2025
Q1 | $1.28B | Sell |
|
|||||
|
2024
Q4 | $1.34B | Sell |
|
|||||
|
2024
Q3 | $1.21B | Sell |
|
|||||
|
2024
Q2 | $1.83B | Buy |
|
|||||
|
2024
Q1 | $1.81B | Buy |
|
|||||
|
2023
Q4 | $1.32B | Sell |
|
|||||
|
2023
Q3 | $1.22B | Sell |
|
|||||
|
2023
Q2 | $1.67B | Sell |
|
|||||
|
2023
Q1 | $1.51B | Sell |
|
|||||
|
2022
Q4 | $1.43B | Sell |
|
|||||
|
2022
Q3 | $1.67B | Sell |
|
|||||
|
2022
Q2 | $2.06B | Sell |
|
|||||
|
2022
Q1 | $2.57B | Sell |
|
|||||
|
2021
Q4 | $2.87B | Sell |
|
|||||
|
2021
Q3 | $2.53B | Sell |
|
|||||
|
2021
Q2 | $2.42B | Buy |
|
|||||
|
2021
Q1 | $1.94B | Buy |
|
|||||
|
2020
Q4 | $1.99B | Buy |
|
|||||
|
2020
Q3 | $1.64B | Buy |
|
|||||
|
2020
Q2 | $1.41B | Buy |
|
|||||
|
2020
Q1 | $1.24B | Buy |
|
|||||
|
2019
Q4 | $1.45B | Sell |
|
|||||
|
2019
Q3 | $1.43B | Sell |
|
|||||
|
2019
Q2 | $1.26B | Sell |
|
|||||
|
2019
Q1 | $1.32B | Sell |
|
|||||
|
2018
Q4 | $1.08B | Sell |
|
|||||
|
2018
Q3 | $1.27B | Sell |
|
|||||
|
2018
Q2 | $1.09B | Sell |
|
|||||
|
2018
Q1 | $1.11B | Buy |
|
|||||
|
2017
Q4 | $854M | Buy |
|
|||||
|
2017
Q3 | $569M | Sell |
|
|||||
|
2017
Q2 | $627M | Buy |
|
|||||
|
2017
Q1 | $191M | Buy |
|
|||||
|
2016
Q4 | $172M | Buy |
|
|||||
|
2016
Q3 | $221M | Sell |
|
|||||
|
2016
Q2 | $185M | Sell |
|
|||||
|
2016
Q1 | $172M | Sell |
|
|||||
|
2015
Q4 | $197M | Sell |
|
|||||
|
2015
Q3 | $190M | Sell |
|
|||||
|
2015
Q2 | $261M | Buy |
|
|||||
|
2015
Q1 | $242M | Buy |
|
|||||
|
2014
Q4 | $161M | Buy |
|
|||||
|
2014
Q3 | $119M | Buy |
|
|||||
|
2014
Q2 | $98.4M | Sell |
|
|||||
|
2014
Q1 | $92.2M | Sell |
|
|||||
|
2013
Q4 | $84.7M | Sell |
|
|||||
|
2013
Q3 | $103M | Sell |
|
|||||
|
2013
Q2 | $103M | Buy |
|